Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Kada

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Ejhaem|July 18, 2022
Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patientsSatoshi Yamasaki, Akiko Kada, Ilseung Choi, et al.
Acta Medica Okayama|August 25, 2018
The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II StudyYuhki Koga, Shingo Baba, Reiji Fukano, et al.
BMJ Open|March 24, 2016
Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study)Daisuke Onozuka, Akihito Hagihara, Kunihiro Nishimura, et al.
Journal of the American Heart Association|October 23, 2014
Consciousness level and off-hour admission affect discharge outcome of acute stroke patients: a J-ASPECT studySatoru Kamitani, Kunihiro Nishimura, Fumiaki Nakamura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2025
A Prospective Phase II Trial of First-Line Osimertinib for Patients With EGFR Mutation-Positive NSCLC and Poor Performance Status (OPEN/TORG2040)Tomoya Fukui, Nobuaki Mamesaya, Toshiaki Takahashi, et al.
Trials|March 14, 2026
Granulocyte-macrophage colony-stimulating factor-containing medium for blastocyst recovery culture: study protocol for a randomized controlled trial (GSET-study)Tatsuya Kobayashi, Kyoko Higuchi, Miki Okabe-Kinoshita, et al.
Cardiovascular Drugs and Therapy|January 9, 2015
Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)Masanori Asakura, Haruko Yamamoto, Kuniya Asai, et al.
Annals of Vascular Diseases|October 23, 2019
Deep Vein Thrombosis in Severe Motor and Intellectual Disabilities Patients and Its Treatment by Anticoagulants of Warfarin Versus EdoxabanHiromitsu Ohmori, Akiko Kada, Mashio Nakamura, et al.
The Lancet. Healthy Longevity|September 13, 2022
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trialYoshihito Kogure, Shunichiro Iwasawa, Hideo Saka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 24, 2020
Measuring Quality of Care for Ischemic Stroke Treated With Acute Reperfusion Therapy in Japan　- The Close The Gap-StrokeNice Ren, Ataru Nishimura, Ai Kurogi, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Ejhaem|July 18, 2022
Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patientsSatoshi Yamasaki, Akiko Kada, Ilseung Choi, et al.
Acta Medica Okayama|August 25, 2018
The Effect of Interim FDG-PET-guided Response-Adapted Therapy in Pediatric Patients with Hodgkin's Lymphoma (HL-14) : Protocol for a Phase II StudyYuhki Koga, Shingo Baba, Reiji Fukano, et al.
BMJ Open|March 24, 2016
Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease: a nationwide retrospective cohort study (J-ASPECT study)Daisuke Onozuka, Akihito Hagihara, Kunihiro Nishimura, et al.
Journal of the American Heart Association|October 23, 2014
Consciousness level and off-hour admission affect discharge outcome of acute stroke patients: a J-ASPECT studySatoru Kamitani, Kunihiro Nishimura, Fumiaki Nakamura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2025
A Prospective Phase II Trial of First-Line Osimertinib for Patients With EGFR Mutation-Positive NSCLC and Poor Performance Status (OPEN/TORG2040)Tomoya Fukui, Nobuaki Mamesaya, Toshiaki Takahashi, et al.
Trials|March 14, 2026
Granulocyte-macrophage colony-stimulating factor-containing medium for blastocyst recovery culture: study protocol for a randomized controlled trial (GSET-study)Tatsuya Kobayashi, Kyoko Higuchi, Miki Okabe-Kinoshita, et al.
Cardiovascular Drugs and Therapy|January 9, 2015
Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER)Masanori Asakura, Haruko Yamamoto, Kuniya Asai, et al.
Annals of Vascular Diseases|October 23, 2019
Deep Vein Thrombosis in Severe Motor and Intellectual Disabilities Patients and Its Treatment by Anticoagulants of Warfarin Versus EdoxabanHiromitsu Ohmori, Akiko Kada, Mashio Nakamura, et al.
The Lancet. Healthy Longevity|September 13, 2022
Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trialYoshihito Kogure, Shunichiro Iwasawa, Hideo Saka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 24, 2020
Measuring Quality of Care for Ischemic Stroke Treated With Acute Reperfusion Therapy in Japan　- The Close The Gap-StrokeNice Ren, Ataru Nishimura, Ai Kurogi, et al.
Pageof 12